Physician profile
Allison MD Han
NPI 1316408214
$1,169.22
in general payments reported to CMS, 2019-2025
12 companies · $292 in 2025
The $292 reported for 2025 was less than what a typical Pediatric Dermatology provider received nationally (typical 2025 total: $302).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $69.79 · 2021: $404 · 2022: $69.00 · 2023: $177 · 2024: $158 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $527 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $526.83 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $271.21 | 2021-2025 | Tremfya |
| Genzyme Corporation | $176.66 | 2024-2025 | |
| Vyne Pharmaceuticals INC. | $172.62 | 2020-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $138.00 | 2021-2022 | |
| Arcutis Biotherapeutics, INC. | $128.79 | 2023 | |
| Abbvie INC. | $104.56 | 2021 | |
| Incyte Corporation | $57.03 | 2024-2025 | Opzelura |
| Ucb, INC. | $33.15 | 2025 | Bimzelx |
| Verrica Pharmaceuticals INC. | $24.81 | 2023 | Ycanth |
| Pfizer INC. | $23.17 | 2023 | |
| Dermavant Sciences, INC. | $22.41 | 2024 | Vtama |
| Exelixis INC. | $16.81 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Han listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.